Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine for Postoperative Analgesia in Spine Fusion
NCT04964219Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Feb 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain, sponsored by Peking University First Hospital. Primary endpoint: Percentage of patients with moderate-to-severe pain at 48 hours. Started Feb 2022; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04964219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964219.